SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-109335
Filing Date
2021-08-25
Accepted
2021-08-25 16:15:46
Documents
12
Period of Report
2021-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FROM 8K tm2125821d1_8k.htm   iXBRL 8-K 24179
  Complete submission text file 0001104659-21-109335.txt   197592

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20210825.xsd EX-101.SCH 3191
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20210825_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20210825_pre.xml EX-101.PRE 22714
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2125821d1_8k_htm.xml XML 3595
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 211207055
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences